Pitfalls and novel experimental approaches to optimize microbial interventions for chemotherapy-induced gastrointestinal mucositis
Open Access
- 1 June 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Supportive & Palliative Care
- Vol. 14 (2) , 127-134
Abstract
Purpose of review: There is a growing number of studies implicating gut dysbiosis in mucositis development. However, few studies have shed light on the causal relationship limiting translational potential. Here, we detail the key supportive evidence for microbial involvement, candidate mechanisms by which the microbiome may contribute to mucositis and emerging approaches to model host–microbe interactions with clinical relevance and translational potential.Recent findings: Synthesis of existing clinical data demonstrate that modulating the microbiome drastically alters the development and severity of mucositis, providing a strong rationale for its involvement. Review of the literature revealed potential microbiome-dependent mechanisms of mucosal injury including altered drug metabolism, bile acid synthesis and regulation of the intestinal barrier. Current studies are limited in their mechanistic insight due to cross-sectional and would benefit from longitudinal analyses and baseline phenotyping.Summary: The causative role of the microbiome in mucositis development remains unclear. Future studies must adopt comprehensive microbial analyses with functional assessment, and utilize emerging ex-vivo models to interrogate host–microbe interactions in mucositis.Keywords
This publication has 62 references indexed in Scilit:
- Chemotherapy-induced mucositis: The role of mucin secretion and regulation, and the enteric nervous systemNeuroToxicology, 2013
- Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinasesSupportive Care in Cancer, 2013
- Changes in Human Fecal Microbiota Due to Chemotherapy Analyzed by TaqMan-PCR, 454 Sequencing and PCR-DGGE FingerprintingPLOS ONE, 2011
- Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trialMucosal Immunology, 2011
- The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced MucositisPLOS Pathogens, 2010
- Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patientsPediatric Blood & Cancer, 2009
- Gastrointestinal Microflora and Mucins May Play a Critical Role in the Development of 5-Fluorouracil-Induced Gastrointestinal MucositisExperimental Biology and Medicine, 2009
- VSL#3 probiotic treatment reduces chemotherapy-induced diarrhoea and weight lossCancer Biology & Therapy, 2007
- Prophylaxis of Irinotecan-Induced Diarrhea with Neomycin and Potential Role for UGT1A1*28 Genotype Screening: A Double-Blind, Randomized, Placebo-Controlled StudyThe Oncologist, 2006
- Perspectives on cancer therapy-induced mucosal injuryCancer, 2004